Pfizer appears to be past COVID with $43 bln deal for most cancers drug maker Seagen ReutersPfizer Agrees to Obtain Seagen for $43 Billion The Wall Street JournalPfizer appears further than Covid revenue with $43 billion deal for most cancers drugmaker Seagen CNBCPfizer purchases Seagen for $43B, boosts access to most cancers drugs ABC NewsBreakingviews – Pfizer’s $43 bln offer is a pricey pipeline fix ReutersView Total Coverage on Google News
News Rant